Associate Professor; Service Chief; Deputy Director IBC Program
Radiation Oncology
Dr. Wendy A. Woodward, MD
|
|
Give Review
Wendy Woodward practices Radiation Oncology. She attended Jefferson Medical College. She received awards:"Robert M. Chamberlain Distinguished Mentor Award", "Honorable Mention, 5th Annual Awards for Excellence in Training and Mentorship in Cancer Prevention", "Finalist, Robert M. Chamberlain Distinguished Mentor Award", "Best Doctors in America", "Next Generation Investigator Award", "Gilbert H. Fletcher Award, Residency Research Award", "Roentgen Research Award", "Eleanor Montague Prize, Residency Research Award", "Merit Award", "Young Oncologist Essay Award", "Intern of the Year", "Alpha Omega Alpha Medical Honor Society", "Foerderer Fellowship", "Sigma Xi Honor Society", "Gibbon Scholar", "Abbey Turner Howe Prize for Excellence in Biology", "Louisa Stone Stevenson Chemistry Award" and "Whos Who in Medicine and Healthcare". Wendy Woodward is a published doctor and has 98 publications published. The lastest was: 'Epidemiological risk factors associated with inflammatory breast cancer subtypes.' She is registered with Medicare and accepts Medicare payments.
Publications
- Epidemiological risk factors associated with inflammatory breast cancer subtypes.
- Inflammatory breast cancer: unique biological and therapeutic considerations.
- Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
- Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.
- Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique.
- Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at six months compared to conventionally fractionated whole breas...
- Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.
- Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes.
- ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.
- Postmastectomy radiation therapy for inflammatory breast cancer: is more better?
- Web based pathology assessment in RTOG 98-04.
- Implementation of the American College of Surgeons Oncology Group Z1071 Trial Data in Clinical Practice: Is There a Way Forward for Sentinel Lymph Node Dissection in C...
- Simvastatin Radiosensitizes Differentiated and Stem-Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients ...
- Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment.
- Statistical Modeling Approach to Quantitative Analysis of Interobserver Variability in Breast Contouring.
- Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.
- Shortened Radiation Therapy Schedules for Early-Stage Breast Cancer: A Review of Hypofractionated Whole-Breast Irradiation and Accelerated Partial Breast Irradiation.
- Aldehyde Dehydrogenase 1 Expression in Inflammatory Breast Cancer as Measured by Immunohistochemical Staining.
- Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
- TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase.
- Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?
- Statin use in primary inflammatory breast cancer: a cohort study.
- Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients.
- Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
- Genomic and expression analysis of microdissected inflammatory breast cancer.
- Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy.
- Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.
- The Value of Ultrasound in Detecting Extra-Axillary Regional Node Involvement in Patients with Advanced Breast Cancer.
- Field match verification during combination proton, photon, and electron therapy for oligometastatic inflammatory breast cancer.
- Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
- Identifying factors that impact survival among women with inflammatory breast cancer.
- Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.
- Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer.
- Triple-negative breast cancer is not a contraindication for breast conservation.
- BikDD Eliminates Breast Cancer Initiating Cells and Synergizes with Lapatinib for Breast Cancer Treatment.
- Local-Regional Recurrence With and Without Radiation Therapy after Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3n0 Breast Cancer.
- Age and Survival Estimates in Patients Who Have Node-Negative T1ab Breast Cancer by Breast Cancer Subtype.
- Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impac...
- Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
- Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-posi...
- Have we made progress in inflammatory breast cancer? Not so fast.
- Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44âºCD24lo cance...
- EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.
- The impact of age on outcome in early-stage breast cancer.
- Breast cancer stem cell targets.
- Long-Term Outcomes in Patients with Isolated Supraclavicular Nodal Recurrence After Mastectomy and Doxorubicin-Based Chemotherapy for Breast Cancer.
- Inflammatory breast cancer: the disease, the biology, the treatment.
- Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy.
- External-Beam Accelerated Partial Breast Irradiation Using Multiple Proton Beam Configurations.
- Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.
- Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype.
- Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control.
- Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution re...
- Overcoming radiation resistance in inflammatory breast cancer.
- Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids.
- Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions.
- Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study.
- Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.
- Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
- Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer.
- Automatic segmentation of whole breast using atlas approach and deformable image registration.
- Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology).
- The impact of pregnancy on breast cancer outcomes in women<or=35 years.
- Radiation resistance of breast cancer stem cells: understanding the clinical framework.
- Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach.
- Effects of variable placement of superior tangential/supraclavicular match line on dosimetric coverage of level III axilla/axillary apex in patients treated with breas...
- Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis.
- Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines.
- Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.
- Locoregional treatment outcomes after multimodality management of inflammatory breast cancer.
- Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes.
- Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.
- Risk of hypothyroidism in older breast cancer patients treated with radiation.
- The role of locoregional therapy in inflammatory breast cancer.
- Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously: no increase in ipsilateral c...
- Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment.
- Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.
- Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy.
- Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer.
- Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.
- Primary angiosarcomas of the breast.
- A gene signature in breast cancer.
- The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast can...
- Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.
- WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells.
- African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy.
- Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.
- Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mast...
- Prognostic value of nodal ratios in node-positive breast cancer.
- Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
- Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
- Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for re...
- Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy.
- Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.
- miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
- Patched targeting peptides for imaging and treatment of hedgehog positive breast tumors.
- Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma.
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Robert M. Chamberlain Distinguished Mentor Award
- Honorable Mention, 5th Annual Awards for Excellence in Training and Mentorship in Cancer Prevention
- Finalist, Robert M. Chamberlain Distinguished Mentor Award
- Best Doctors in America
- Next Generation Investigator Award
- Gilbert H. Fletcher Award, Residency Research Award
- Roentgen Research Award
- Eleanor Montague Prize, Residency Research Award
- Merit Award
- Young Oncologist Essay Award
- Intern of the Year
- Alpha Omega Alpha Medical Honor Society
- Foerderer Fellowship
- Sigma Xi Honor Society
- Gibbon Scholar
- Abbey Turner Howe Prize for Excellence in Biology
- Louisa Stone Stevenson Chemistry Award
- Whos Who in Medicine and Healthcare
Education
-
University of Texas MD Anderson Cancer Center -
Albert Einstein Healthcare Network -
Jefferson Medical College
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699871558 |
| Last Name Of The Provider | WOODWARD |
| First Name Of The Provider | WENDY |
| View All |
Similar Doctors
|
|
Dr. Sean E. McGuire, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel C. Garner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David I. Rosenthal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita Mahajan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Grosshans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gunar K. Zagars, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas M. Guerrero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George H. Perkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali Mazloom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joe Y. Chang, MD |
|
|
Dr. George G. Chen, MD |
|
|
Dr. Brian J. Deegan, MD |
|
|
Dr. Myrna Godoy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randa Tao, MD |
|
|
Bin S. Teh, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis Bier, MD
This Doctor is OpenDoctor Recommended.
|